{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:43:01Z","timestamp":1776404581434,"version":"3.51.2"},"reference-count":18,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.4103\/0972-5229.198311","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T06:32:23Z","timestamp":1484289143000},"page":"11-16","source":"Crossref","is-referenced-by-count":6,"title":["Experiences with continuous venovenous hemofiltration using 18mmol\/l predilution citrate anticoagulation and a phosphate containing replacement solution"],"prefix":"10.5005","volume":"21","author":[{"given":"Yuen","family":"Jeffrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shum","family":"Hoi-Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kit Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lam","family":"Chung-Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wing-Wa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai","family":"King-Yiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2017]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Monti G, Herrera M, Kindgen-Milles D, Marinho A, Cruz D, Mariano F, et al. The DOse REsponse Multicentre International Collaborative Initiative (DO-RE-MI). Contrib Nephrol 2007;156:434-43.","DOI":"10.1159\/000102137"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Bihorac A, Ross EA. Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition. Am J Kidney Dis 2005;46:908-18.","DOI":"10.1053\/j.ajkd.2005.08.010"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009;37:545-52.","DOI":"10.1097\/CCM.0b013e3181953c5e"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Leung AK, Shum HP, Chan KC, Chan SC, Lai KY, Yan WW. A retrospective review of the use of regional citrate anticoagulation in continuous venovenous hemofiltration for critically ill patients. Crit Care Res Pract 2013;2013:349512.","DOI":"10.1155\/2013\/349512"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Shum HP, Chan KC, Yan WW. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using Prismocitrate 10\/2 solution. Ther Apher Dial 2012;16:81-6.","DOI":"10.1111\/j.1744-9987.2011.01001.x"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Broman M, Carlsson O, Friberg H, Wieslander A, Godaly G. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand 2011;55:39-45.","DOI":"10.1111\/j.1399-6576.2010.02338.x"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Chua HR, Schneider AG, Baldwin I, Collins A, Ho L, Bellomo R. Phoxilium vs. Hemosol-B0 for continuous renal replacement therapy in acute kidney injury. J Crit Care 2013;28:884.e7-14.","DOI":"10.1016\/j.jcrc.2013.02.013"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, et al. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: Effects on acid-base status and phosphate supplementation needs. BMC Nephrol 2013;14:232.","DOI":"10.1186\/1471-2369-14-232"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179-84.","DOI":"10.1159\/000339789"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-52.","DOI":"10.1097\/00003246-200104000-00010"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: A meta-analysis of randomized controlled trials. Am J Kidney Dis 2012;59:810-8.","DOI":"10.1053\/j.ajkd.2011.11.030"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012;38:20-8.","DOI":"10.1007\/s00134-011-2438-3"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006;1:79-87.","DOI":"10.2215\/CJN.00040505"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Brain MJ, Roodenburg OS, Adams N, McCracken P, Hockings L, Musgrave S, et al. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: The filter life in renal replacement therapy pilot trial. Crit Care Resusc 2014;16:131-7.","DOI":"10.1016\/S1441-2772(23)01454-0"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"15. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-38.","DOI":"10.1056\/NEJMoa0902413"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. VA\/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O\u2032Connor TZ, Chertow GM, Crowley ST, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20.","DOI":"10.1056\/NEJMoa0802639"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Jun M, Heerspink HJ, Ninomiya T, Gallagher M, Bellomo R, Myburgh J, et al. Intensities of renal replacement therapy in acute kidney injury: A systematic review and meta-analysis. Clin J Am Soc Nephrol 2010;5:956-63.","DOI":"10.2215\/CJN.09111209"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"18. Brandl M, Strobl K, Hartmann J, Kellner K, Posnicek T, Falkenhagen D. A target-orientated algorithm for regional citrate-calcium anticoagulation in extracorporeal therapies. Blood Purif 2012;33:7-20.","DOI":"10.1159\/000332394"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/0972-5229.198311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T11:29:07Z","timestamp":1749900547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/0972-5229.198311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017]]}},"alternative-id":["10.4103\/0972-5229.198311"],"URL":"https:\/\/doi.org\/10.4103\/0972-5229.198311","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}